European Archives - Page 1103 of 1160 - European Medical Journal

EMJ

All Forms of Smoking Are Bad for the Heart

Sophia Antipolis, 31 May 2015: All forms of smoking are bad for the heart, the European Society of Cardiology (ESC) warned today…

EMJ

Experts across Europe Call for Earlier Detection of Oesophageal Cancer in a Bid to Improve Survival Rates

(May 21, 2015) Recent estimates indicate that more than 34,000 new cases of oesophageal cancer are recorded across Europe annually, with incidence…

EMJ

New Data on BIOTRONIK Orsiro Hybrid Drug-Eluting Stent Demonstrates Enhanced Safety and Three-Times Reduced Risk of Stent Thrombosis

BUELACH, Switzerland, May 26, 2015—BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, announced that positive new…

EMJ

Depression Associated with 5-Fold Increased Mortality Risk in Heart Failure Patients

Seville, Spain – 23 May 2015: Moderate to severe depression is associated with a 5-fold increased risk of all cause mortality in patients with…

EMJ

Cognitive Impairment Predicts Worse Outcome in Heart Failure

Seville, Spain – 24 May 2015: Cognitive impairment predicts worse outcome in elderly heart failure patients, reveals research presented today at…

EMJ

Obesity and Mood Disorders Increase Peripartum Cardiomyopathy Risk

Seville, Spain – 23 May 2015: Obesity and mood disorders increase the risk of peripartum cardiomyopathy (PPCM) during childbirth, reveals research…

EMJ

TITRATION Study Confirms LCZ696 Safe and Tolerated in Clinical Practice

Seville, Spain – 23 May 2015: The TITRATION study has confirmed that LCZ696 is safe and tolerated by patients with heart failure and reduced…

EMJ

Cardiovascular Nurses Discuss the Latest in Evidence Based Care

Sophia Antipolis, 24 May 2015 – The cardiovascular nursing event of the year is heading south to Croatia. EuroHeartCare is the official annual meeting of…

EMJ

STOP-HF: Gene Therapy SDF-1 Remodels Hearts of High Risk Heart Failure Patients

Seville, Spain – 25 May 2015: The gene therapy SDF-1 remodelled the hearts of high risk heart failure patients in the phase II STOP-HF trial…

EMJ

Conservative Management of Prostate Cancer: Favourable 15-Year Outcomes in Older Patients with Low-Risk Disease

SURVIVAL outcomes among patients with low-risk prostate cancer (PrC) are favourable when initially treated with conservative management…